Protection of pregnant mice, fetuses and neonates from lethality of H5N1 influenza viruses by maternal vaccination
Abstract
No abstract availableKeywords
Funding Information
- Korea Healthcare technology R&D Project, Ministry for Health, Welfare & Family Affairs
- Republic of Korea
This publication has 27 references indexed in Scilit:
- Protective Immunity Afforded by Inactivated H5N1 (NIBRG‐14) Vaccine Requires Antibodies against Both Hemagglutinin and Neuraminidase in MiceThe Journal of Infectious Diseases, 2009
- Single- and multiple-clade influenza A H5N1 vaccines induce cross protection in ferretsVaccine, 2009
- Cross-clade protective immunity of H5N1 influenza vaccines in a mouse modelVaccine, 2008
- Effectiveness of Maternal Influenza Immunization in Mothers and InfantsNew England Journal of Medicine, 2008
- Influenza A H5N1 Clade 2.3.4 Virus with a Different Antiviral Susceptibility Profile Replaced Clade 1 Virus in Humans in Northern VietnamPLOS ONE, 2008
- Broad Clade 2 Cross-Reactive Immunity Induced by an Adjuvanted Clade 1 rH5N1 Pandemic Influenza VaccinePLOS ONE, 2008
- Avian Influenza A (H5N1) in 10 Patients in VietnamNew England Journal of Medicine, 2004
- Generation of High-Yielding Influenza A Viruses in African Green Monkey Kidney (Vero) Cells by Reverse GeneticsJournal of Virology, 2004
- Characterization of an Avian Influenza A (H5N1) Virus Isolated from a Child with a Fatal Respiratory IllnessScience, 1998
- Standardization of Inactivated H5N2 Influenza Vaccine and Efficacy against Lethal A/Chicken/Pennsylvania/1370/83 InfectionAvian Diseases, 1985